WHO ICTRP trial
A pilot study for hematopoietic stem cell transplantation with…
JPRN-jRCTs031180397 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs031180397 |
|---|---|
| Public title | A pilot study for hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin |
| Scientific title | A pilot study for hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin from HLA-mismatched related donor for non-malignant diseases |
| Primary sponsor | Kato Motohiro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Bone marrow failure, immunodeficiency, metabolic error |
| Interventions | Conditioning regimen with anti-thymocyte globulin. Stem cell transplantation at day 0. Cyclophosphamide at day 3 and 4. |
| Registration date | Mar 20, 2019 |
| Target size | 9 |
| Secondary IDs | UMIN000026159 |
| Registry page | jrct.niph.go.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: